Is pharmaceutical innovation expensive? How do we reimburse it? Is it worth its money? Should we favor local entrepreneurship over the multi-national market? How? How do we develop an integrated policy that balances tight budgets with the need for continued research and development and economic growth?
At HPI we foster, support, and lead rigorous scientific and comparative research initiatives that inform pharmaceutical policy making with objective, actionable analysis of institutional frameworks to balance conflicting pharmaceutical policy goals.